Sitagliptin – DPP-4 Inhibitor for Type 2 Diabetes
Sitagliptin is an oral antidiabetic drug belonging to the DPP-4 inhibitor class, used to improve blood sugar control in adults with type 2 diabetes.
Things worth knowing about "Sitagliptin"
Sitagliptin is an oral antidiabetic drug belonging to the DPP-4 inhibitor class, used to improve blood sugar control in adults with type 2 diabetes.
What is Sitagliptin?
Sitagliptin is a prescription medication used to treat type 2 diabetes mellitus in adults. It belongs to a class of drugs known as DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) and is marketed under the brand name Januvia. Sitagliptin can be used alone or in combination with other antidiabetic medications such as metformin to help lower and control blood sugar levels.
Indication
Sitagliptin is indicated for adults with type 2 diabetes mellitus when diet and exercise alone are not sufficient to achieve adequate blood sugar control. It may be used:
- as monotherapy when metformin is not tolerated or is contraindicated
- in combination with metformin, sulfonylureas, SGLT-2 inhibitors, or insulin
Sitagliptin is not intended for use in type 1 diabetes or diabetic ketoacidosis.
Mechanism of Action
Sitagliptin selectively and reversibly inhibits the enzyme dipeptidyl peptidase-4 (DPP-4). This enzyme is responsible for the rapid breakdown of incretin hormones – primarily GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
By inhibiting DPP-4, sitagliptin prolongs the activity of these incretin hormones, leading to:
- Enhanced insulin secretion from pancreatic beta cells (in a glucose-dependent manner)
- Reduced glucagon secretion from pancreatic alpha cells (also glucose-dependent)
- Improved control of postprandial blood glucose levels (blood sugar after meals)
Because the mechanism is glucose-dependent, sitagliptin carries a relatively low risk of hypoglycemia (low blood sugar) when used as monotherapy.
Dosage
The recommended standard dose for adults is 100 mg of sitagliptin once daily, with or without food. Dose adjustments are required for patients with impaired kidney function:
- Moderate kidney impairment (eGFR 30–45 mL/min): 50 mg once daily
- Severe kidney impairment or end-stage renal disease (eGFR below 30 mL/min): 25 mg once daily
Dosage should always be determined in consultation with a healthcare provider.
Side Effects
Sitagliptin is generally well tolerated. The most common side effects include:
- Upper respiratory tract infections (nasopharyngitis)
- Headache
- Hypoglycemia (especially when combined with sulfonylureas or insulin)
- Nausea and abdominal discomfort
Rare but serious side effects include:
- Pancreatitis (inflammation of the pancreas): Patients experiencing persistent, severe abdominal pain should seek medical attention immediately.
- Severe allergic reactions (e.g., angioedema, Stevens-Johnson syndrome)
- Joint pain (arthralgia): Severe and persistent joint pain has been reported in some cases.
Contraindications and Interactions
Sitagliptin should not be used in patients with:
- Hypersensitivity to the active substance
- Type 1 diabetes mellitus
- Diabetic ketoacidosis
Important drug interactions include:
- Sulfonylureas and insulin: increased risk of hypoglycemia; dose reduction may be necessary
- Digoxin: sitagliptin may slightly increase digoxin plasma levels; monitoring is recommended
References
- European Medicines Agency (EMA): Januvia (Sitagliptin) – Summary of Product Characteristics. www.ema.europa.eu
- American Diabetes Association (ADA): Standards of Medical Care in Diabetes – 2024. Diabetes Care, 2024.
- Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet. 2006;368(9548):1696-1705.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryCalorie deficit
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Sitagliptin-en